Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gold and Silver Thirty-Seven Capsules (Jinyin Sanqi Jiaonang) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Guangxi Golden Throat. It is an oral capsule formulation containing two primary herbal ingredients: Jin Yin Hua (*Lonicera japonica*, also known as Honeysuckle) and San Qi (*Panax notoginseng*). In TCM theory, Jin Yin Hua is used to clear heat and detoxify, while San Qi is used to transform blood stasis and reduce swelling. The product is marketed as an over-the-counter (OTC) consumer health item in China, typically indicated for conditions involving inflammation, sore throat, or to support general wellness according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gold and Silver Thirty-Seven Capsules.